Resveratrol Reduces Ovarian, Adrenal Androgens in PCOS

This article originally appeared here.
Share this content:
Resveratrol Reduces Ovarian, Adrenal Androgens in PCOS
Resveratrol Reduces Ovarian, Adrenal Androgens in PCOS

THURSDAY, Oct. 20, 2016 (HealthDay News) -- For patients with polycystic ovary syndrome (PCOS), resveratrol is associated with significant reductions in ovarian and adrenal androgens, according to a study published online Oct. 18 in the Journal of Clinical Endocrinology & Metabolism.

Beata Banaszewska, M.D., Ph.D., from the Poznan University of Medical Sciences in Poland, and colleagues evaluated endocrine and metabolic effects of resveratrol on PCOS in a randomized placebo-controlled trial conducted over a three-month period. Thirty-four patients were enrolled in the trial and 30 completed the trial.

The researchers observed a significant 23.1 percent decrease in total testosterone with resveratrol (P = 0.1). Resveratrol also induced a 22.2 percent decrease in dehydroepiandrosterone sulfate, a 31.8 percent decrease in fasting insulin level, and a 66.3 percent increase in the Insulin Sensitivity Index (P = 0.01, 0.007, and 0.04, respectively). There were no significant alterations in the levels of gonadotropins, lipid profiles, and markers of inflammation and endothelial function.

"Resveratrol significantly reduced ovarian and adrenal androgens," the authors write. "This effect may be, at least in part, related to an improvement of insulin sensitivity and a decline of insulin level."

RevGenetics provided resveratrol for this study. The Adamed Group partially supported the study and produced the placebo pills.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Nocturia May Be Reduced by Cutting Daily Intake of Salt

Nocturia May Be Reduced by Cutting Daily Intake ...

An easy way for patients to reduce nighttime urination and subsequent impact on sleep

Smoking Ups Long-Term Risks From Radiotherapy in Breast CA

Smoking Ups Long-Term Risks From Radiotherapy in Breast ...

Risk associated with radiotherapy for breast cancer is substantially reduced with smoking cessation

Impact of Breastfeeding on Child Development May Be Short-Lived

Impact of Breastfeeding on Child Development May Be ...

After propensity matching, only statistically significant outcome was hyperactivity at age 3 years

is free, fast, and customized just for you!

Already a member?

Sign In Now »